Buserelin
GnRH receptor agonist used as clinical reference compound for endocrine research.
Open Buserelin in the 3D analyzerAnalytical specification
| Empirical formula | C60H86N16O13 |
|---|---|
| Molecular weight | 1239.4 g/mol |
| Isoelectric point (pI) | 9.90 |
| Assay purity (HPLC) | 99.70% |
| Retention time | 5.60 min |
| Peak area / height | 11100 / 890 |
| Reference batch | BU-2026-X88 |
| Research category | Immune, Solvents & Others |
| Amino-acid sequence | Pyr-H-W-S-Y-D-Ser(tBu)-L-R-P-NHEt |
Research characteristics
Endocrine Agonist
Extremely potent LHRH pathway target
Dosing Baseline
Ensures precise research control metrics
Cell Protection
Protects cellular baseline viability profiles
High Assay Score
Zero chemical byproduct degradation
Reconstitution
Use the interactive reconstitution calculator to convert vial size (mg), bacteriostatic water volume (ml) and target dose (mcg) into a syringe draw on a standard 100-unit insulin syringe. Open the dosage calculator.
Related immune, solvents & others compounds
Tuftsin
Naturally occurring tetrapeptide phagocytosis-stimulating agent evaluated for immune defense.
Thymosin Alpha-1 (Immune)
Immunomodulating Thymosin Alpha-1 segment evaluated for systemic immune response optimization.
LL-37 (Immune Grade)
Cathelicidin immune segment researched for biofilm disruption and cellular pathogens defense.
KPV (Dermal & Immune)
Purified KPV tripeptide tailored for contact dermatitis and systemic cytokine balancing studies.
Thymopentin (Immune)
Thymopentin (TP-5) segment targeting lymphocyte maturation and cellular immune validation.
Splenopentin (SP-5)
Splenic peptide analog evaluated for T-cell subset balance and antibody optimization.